One jab vaccine approved

The medicines regulator, Swissmedic, has given the go ahead to the one-shot vaccine from the US company Johnson and Johnson.

Sometimes known as the Janssen Vaccine, it has a 66.9% efficacy rate in those over 18 years old. 

The drug was put forward for authorisation in December. 

The vaccine has been used in the United States since February. 

As yet, there’s no information  when it will start to be used. 
 

More from Bitesize News

  • Bank details compromised

    British digital bank Revolut has admitted handing customer information to fraudsters who impersonated a European government agency

  • Watch theft victim speaks out

    A luxury watch dealer just across the French border from Geneva has broken his silence about a violent robbery earlier this month

  • Crans Montana hearings due before end of year

    Jessica Moretti, who ran the Constellation bar in Crans-Montana, is now living in near-isolation in the Valais village of Lens more than eight months after the deadly New Year's Eve fire

  • Better news for economy

    Switzerland's economy will grow 1.7% this year — nearly double the 0.9% expansion forecast in June, the State Secretariat for Economic Affairs said yesterday

  • Geneva budget plan unveiled

    Geneva has now put figures to its austerity plan — a CHF 546 million deficit for 2027, even after CHF 247 million in cuts

  • Summer fires increase

    Firefighters across French-speaking Switzerland tackled far more vegetation fires this summer than in any of the past five years

Download our app

  • Available on the App Store
  • Available on Google Play